Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages

  Ceperuelo Mallafré, Victòria ^a,b   Duran, Xavier ^a   Pachón, Gisela ^a,c   Roche, Kelly ^a,c   Garrido Sánchez, Lourdes ^a,b   Vilarrasa, Nuria ^a,d   Tinahones, Francisco J ^a,b   Vicente, Vicente ^c   Pujol, Jordi ^d   Vendrell, Joan ^a,c   Fernández Veledo, Sonia ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; G PROTEIN COUPLED RECEPTOR KINASE 2; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GLUCOSE; HORMONE RECEPTOR; INCRETIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; ARTICLE; BODY MASS; CELL HYPOXIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GIPR GENE; GLUCOSE TRANSPORT; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; AGED; BODY MASS INDEX; CELL LINE; DOWN-REGULATION; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RECEPTORS, GASTROINTESTINAL HORMONE; SIGNAL TRANSDUCTION; WAIST CIRCUMFERENCE;

EID: 84899956174     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3350     Document Type: Article

References (39)

1. Drucker DJ. The biology of incretin hormones. Cell Metab. 2006; 3:153-165.
2. Cefalu WT. Evolving treatment strategies for the management of type 2 diabetes. Am J Med Sci. 2012;343:21-26.
3. Vilsbø ll T, Krarup T , Madsbad S, Holst JJ. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia. 2002;45:1111-1119.
4. Speliotes EK, Willer CJ , Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937-948.
5. Miyawaki K,YamadaY, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002;8:738-742.
6. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR. GIP receptor antagonism rev erses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab. 2007; 293:E1746-E1755.
7. Althage MC, Ford EL , Wang S, Tso P, Polonsky KS, Wice BM. Targeted ablation of glucose-dependent insulinotropic polypeptideproducing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem. 2008;283:18365-18376.
8. Fulurija A, Lutz TA, Sladko K, et al. Vaccination against GIP for the treatment of obesity. PloS One. 2008;3:e3163.
9. Kim SJ, Nian C, Karunakaran S, Clee SM, Isales CM, McIntosh CH. GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis. PloS One. 2012; 7: e40156.
10. Yip RG, Wolfe MM. GIP biology and fat metabolism. Life Sci. 2000;66:91-103.
11. Kim SJ, Nian C, McIntosh CH. GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene. J Lipid Res. 2010;51:3145-3157.
12. Song DH, Getty-Kaushik L, Tseng E, Simon J, Corkey BE, Wolfe MM. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterolo gy. 2007;133:1796-1805.
13. Miyawaki K, Yamada Y, Yano H, et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999;96:14843-14847.
14. Starich GH, Bar RS, Mazzaferri EL. GIP increases insulin receptor affinity and cellular sensitivity in adipocytes. Am J Physiol. 1985; 249:E603-E607.
15. MohammadS,RamosLS, Buck J, Levin LR, Rubino F,McGrawTE. Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110-isofo rm of phosphatidylinositol 3-kinase. J Biol Chem. 2011;286: 43062-43070.
16. Nie Y, Ma RC, Chan JC, Xu H, Xu G. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducin g adipocyte inflammation in glucose-dependent insulinotropic peptide receptoroverexpressing adipocytes. FASEB J. 2012;26:2383-2393.
17. Timper K, Grisouard J, Sauter NS, et al. Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes. Am J Physiol Endocrinol Metab. 2013;304:E1-E13.
18. Rudovich N, Kaiser S, Engeli S, et al. GIP receptormRNAexpression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept. 2007;142:138-145.
19. Cardona F Morcillo S Gonzalo-Marín M Garrido-Sanchez L Macias-Gonzalez M Tinahones FJ. Pro12Ala sequence variant of the PPARGgene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome Clin Chem. 2006 52 1920-1925.
20. Wabitsch M, Brenner RE, Melzner I, et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 2001;25:8-15.
21. Vendrell J,Maymó-MasipE, Tinahones F, et al.Tumornecrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin En docrinol Metab. 2010;95: 2983-2992.
22. Pachón-Pe na G, Yu G, Tucker A, et al. Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic pro files. J Cell Physiol. 2011;226: 843-851.
23. Ferná ndez-Veledo S, Vila-Bedmar R, Nieto-Vazquez I, Lorenzo M. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-induces insulin resista nce in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab. 2009;94:3583-3593.
24. Tseng CC, Zhang XY. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling. Endocrinology. 2000;141:947-952.
25. Mayor F Jr., Lucas E, Jurado-Pueyo M, et al. G Protein-coupled receptor kinase 2 (GRK2): a novel modulator of insulin resistance. Arch Physiol Biochem. 2011;117:125-130.
26. Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, et al.Gproteincoupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes. 2010;59:2407-2417.
27. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93:1-21.
28. Lamers D, Famulla S, Wronkowitz N, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60:1917-1925.
29. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta. 2010;1801:338-349.
30. Ahlqvist E, Osmark P, Kuulasmaa T, et al. Link between GIP and osteopontin in adipose tissue and insulin resistance. Diabetes. 2013; 62:2088-2094.
31. Højb erg PV, Vilsbø ll T, Zander M, et al. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with type 2 diabetes. D iabet Med. 2008;25:1268-1275.
32. Vendrell J, El Bekay R, Peral B, et al. Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology. 2011;152:4072-4079.
33. Pérez LM, Bernal A, San Martín N, Lorenzo M, Fernández-Veledo S, Gálvez BG. Metabolic rescue of obese adipose-derived stem cells by lin28/let7 pathway. Diabetes. 2013;62:2368-2379.
34. Parlevliet ET, de Leeuw van Weenen JE, Romijn JA, Pijl H. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat d iet. Am J Physiol Endocrinol Metab. 2010;299:E318-E324.
35. Villanueva-Pen acarrillo ML, Martín-Duce A, Ramos-Álvarez I, et al. Characteristic of GLP-1 effects on glucose metabolism in human skel etal muscle from obese patients. Regul Pept. 2011;168:39-44.
36. Hauner H, Glatting G, Kaminska D, Pfeiffer EF. Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isola ted rat adipocytes. Ann Nutr Metab. 1988;32:282-288.
37. Kim SJ, Nian C, McIntosh CH. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a pro tein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem. 2007;282:8557-8567.
38. Kim SJ, Nian C, McIntosh CH. Adipocyte expression of the glucosedependent insulinotropic polypepti de receptor involves gene regulation by PPAR-and histone acetylation. J Lipid Res. 2011;52: 759-770.
39. Berdasco M, Melguizo C, Prados J, et al. DNA methylation plasticity of human adipose-derived stem cells in lineage commitment. Am J Pathol. 2012;181:2079-2093.